お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
927371

光線力学がん治療 (がんに対する光線力学療法 (PDT)) の世界市場:臨床試験の考察

Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2026

出版日: | 発行: KuicK Research | ページ情報: 英文 160 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.83円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。制限内容はお問合せください。
Multi-User License: 会社全体での使用権

光線力学がん治療 (がんに対する光線力学療法 (PDT)) の世界市場:臨床試験の考察
出版日: 2020年03月01日
発行: KuicK Research
ページ情報: 英文 160 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

光線力学がん治療は、たった1つの光源でがん細胞を破壊することができます。これまで、泌尿器、循環器、歯科、免疫学、眼科、皮膚科などのいくつかの医療分野で、治療の潜在的な結果が見られました。

当レポートでは、世界のがんに対する光線力学療法 (PDT) 市場について調査分析し、市場機会、臨床パイプライン、上市品、治験情勢などについて、体系的な情報を提供しています。

目次

第1章 光線力学がん治療とは?

  • 概要
  • 光線力学がん治療の利点
  • 光線力学がん治療の進化

第2章 なぜがん治療に光線力学療法 (PDT) が必要なのか?

第3章 光線力学がん治療の手続きのフレームワーク

  • 光線力学療法 (PDT) の手順
  • 身体への光増感剤の投与
  • 酸素 - 光線力学療法 (PDT) の重要な基質
  • 光源 - 光増感剤の安全で効果的な活性化のために

第4章 光増感剤のデリバリーによる光線力学療法 (PDT) の有効性の改善

  • 有機ナノ粒子の役割:増幅された薬物負荷と溶解度の増加
  • 光線力学療法 (PDT) における光増感剤の無機ナノ担体

第5章 光線力学療法 (PDT) の抗腫瘍活性

  • 直接的な腫瘍光線力学療法 (PDT) による損傷
  • 血管損傷
  • 炎症性・免疫反応

第6章 光線力学療法 (PDT) を使用した複数のがん治療

  • 非黒色腫皮膚がん
  • 前立腺がん
  • 乳がん
  • 脳腫瘍
  • 肺がん
  • 頭頸部がん
  • 口腔病変・食道がん
  • 子宮頸がん
  • 大腸がん
  • 胆管がんと膵臓がん

第7章 光線力学がん治療の併用 - 腫瘍成長の完全な根絶への一歩

第8章 光線力学療法 (PDT) セグメントの進歩

  • 乳がんに対する細胞内「活性化」二光子光線力学療法 (PDT)
  • 金ナノクラスター:光線力学療法 (PDT) の新しいナノテクノロジーイノベーション
  • 微生物アジュバントとサイトカインを使用した光線力学療法 (PDT) と併用療法

第9章 世界のがん治療用光増感剤の臨床パイプラインの概要

  • フェーズ別
  • 国別
  • 企業別

第10章 世界のがん治療用光増感剤の臨床パイプライン:企業別、適応別、フェーズ別

  • 研究
  • 前臨床
  • フェーズII
  • フェーズIII

第11章 上市済みのがん治療用光増感剤:企業別、適応別

  • Ameluz
  • UVADEX
  • Photobarr/Photofrin
  • Foscan
  • Cevira
  • Metvix
  • TOOKAD Soluble
  • Aptocine/Laserphyrin/Leserfin/Litx

第12章 光線力学療法 (PDT) に関する産業考察を明らかにする商業情報

  • 新規化合物による光線力学療法 (PDT) の進歩
  • 光線力学療法 (PDT) をより効果的にするための新しい技術の採用
  • 酸素依存性薬物をより効率的な化合物に置き換える
  • ゲルへの外科的注射の時代に革命を起こす

第13章 世界の光線力学療法 (PDT) 市場:現在のシナリオと腫瘍学セグメントにおけるその役割

  • 世界の光線力学療法 (PDT) 市場分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ、中東・アフリカ

第14章 世界の光線力学がん治療の市場力学

  • 成長の好ましいパラメーター
  • 将来の市場成長への課題

第15章 世界の光線力学がん治療市場の将来の見通し

第16章 競合情勢

  • Theralase Technologies
  • Dusa Pharmaceuticals
  • Biofrontera AG
  • Soligenix
  • Coherent
  • Lumenis
  • Nanoprobes
  • PhotoMedex
  • Biolitec
  • Ambicare Health
  • Quest Pharma Tech
  • Photolitec
図表

List of Figures

  • Figure 1-1: Superiority of Cancer Photodynamic Therapy over Other Methods
  • Figure 1-2: Evolution of Photodynamic Therapy
  • Figure 2-1: The Need for Cancer Photodynamic Therapy
  • Figure 3-1: Working Principle of Photodynamic Therapy
  • Figure 3-2 : Desired Features of an Ideal Photosensitizer
  • Figure 3-3 : Cellular Mechanism of Photodynamic Therapy
  • Figure 3-4: Various Types of Light Sources Used in Photodynamic Therapy
  • Figure 4-1: Drug Carriers for Photodynamic Therapy
  • Figure 4-2 : Delivery of Photosensitizer Drugs Using Liposomes
  • Figure 4-3: Structure of a Quantum Dot
  • Figure 4-4: Gold Nanoparticles for Targeted Delivery of Photosensitizers
  • Figure 5-1: Apoptosis of Tumor Cell Induced by Photodynamic Therapy
  • Figure 5-2 : Vascular Damage of Tumor Cells Induced By Photodynamic Cancer Therapy
  • Figure 5-3 : Tumor Cell Death Pathways by Reactive Oxygen Species
  • Figure 6-1 : Photodynamic Therapy for Lung Cancer
  • Figure 6-2 : Photodynamic Therapy for the treatment of Cervical Cancer
  • Figure 7-1 : Limitation of Cancer Photodynamic Therapy
  • Figure 9-1: Global - Cancer Photosensitisers Clinical Pipeline by Phase (Numbers), 2020 till 2026
  • Figure 9-2: Global - Cancer Photosensitisers Clinical Pipeline by Phase (%), 2020 till 2026
  • Figure 9-3: Global - Cancer Photosensitisers Clinical Pipeline by Company (Numbers), 2020 till 2026
  • Figure 9-4: Global - Cancer Photosensitisers Clinical Pipeline by Company (Numbers), 2020 till 2026
  • Figure 13-1: Use of Photodynamic Therapy for Various Skin Cancer Types
  • Figure 13-2: Global - Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018-2026
  • Figure 13-3: Global - Cancer Photodynamic Therapy Shares by Devices and Essentials
  • Figure 13-4: Global - Share of Cancer In Photodynamic Therapy (%), 2019
  • Figure 13-5: Global - Share of Cancer In Photodynamic Therapy (%), 2026
  • Figure 13-6: Global - Cancer Photodynamic Therapy by Region (%), 2019
  • Figure 13-7: Global - Cancer Photodynamic Therapy by Region (%), 2026
  • Figure 13-8: US - Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026
  • Figure 13-9: Europe - Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026
  • Figure 13-10: Asia - Cancer Photodynamic Therapy Market Opportunity (US$ Billion), 2018 & 2026
  • Figure 14-1: Global - Driving Factors of the Cancer Photodynamic Therapy Market
  • Figure 14-2: Global - Breast, Lung & Skin Cancer Statistics
  • Figure 14-3: Global - Cancer Photodynamic Therapy Market Challenges
  • Figure 14-4 : Global - Scientific Limitations of the Cancer Photodynamic therapy
  • Figure 14-5 : Global - Commercial Challenges to the Photodynamic Therapy Market
  • Figure 15-1: Global - Future Governing Factors of the Photodynamic Therapy Marke
目次

"Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2026" Report Highlights:

  • Global Cancer Photodynamic Therapy Market Opportunity: > US$ 4 Billion
  • Share of Cancer in Photodynamic Therapy: > 40%
  • US To Dominate Global Photodynamic Therapy Market
  • Global Cancer Photosensitisers Clinical Pipeline: >10 Photosensitisers In Trials
  • Marketed Cancer Photosensitisers: >5
  • US Dominating Global Clinical Trials Landscape: >10 Photosensitisers In Trials

The research report “Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2026” represent an interpretation of ongoing trends and strategies of global photodynamic therapy market. The research report concentrates on providing the information about the present state of the therapy in the overall cancer market which will bring to our readers a deep and valuable insight about the current trends and the overall growth and strength of the therapy at regional and global level. The information presented in the report has been compiled and segmented to highlight the important achievements and the abilities of the market over the other cancer markets.

The therapy majorly focuses on the treatment of the cancer through the agents that are light sensitive. Since its entry in the cancer market, the therapy is observing a huge commercial success. Being a modern and non-invasive therapeutic modern method, the therapy is constantly adding the number of the patients it is treating. The major growth attributer for the market is the fact that the therapy is totally harmless and utilizes only a source of light for processing necrosis in cancer cells.

Cancer photodynamic therapy holds other additional benefits than the traditional cancer treatments like chemotherapy or surgery. The therapy gives an advantage for suitable mode of administration for the cancer agent, thus ignoring the other harmful scenarios that other therapies makes the cancer patient undergo. The agents involved in the therapy can be administered systematically as well as topically. This makes the therapy a priority among the cancer patients. On the basis of priority and the additional benefits the therapy provides, the market of the therapy has presented a scenario which is a boon for the pharmaceutical companies investing in the respective therapy.

Cancer photodynamic treatment is capable of destructing the cancer cells with just one source of light. This makes the treatment a modern, harmless and a convenient therapy. With so many expertise working on the therapy, so far they have discovered the potential outcomes of the therapy in several medical fields such as urology, cardiology, dentistry, immunology, ophthalmology and most importantly dermatology.

In addition to the benefits it has provided the cancer patients in the last few decades, the therapy is continuously being explored for rest of the cancer fields. The level of the successful cancer survival rates with the discovery of photodynamic therapy has experienced a major growth. The need of the effective cancer treatments has already pushed the researchers to think out of the box and photodynamic therapy out of all the other methodologies is a discovery that has gained enough appreciation in a short period of time. The urgency in reducing the cancer mortality rate and providing an effective yet harmless therapy is what will drive the market of the therapy in the future years.

Table of Contents

1. What is Photodynamic Cancer Therapy?

  • 1.1. Overview
  • 1.2. Advantage of Photodynamic Cancer Therapy
  • 1.3. Evolution of the Photodynamic Cancer Therapy

2. Why There Exist Need for Photodynamic Therapy For Cancer Treatment?

3. The Procedural Framework For Photodynamic Cancer Therapy

  • 3.1. Procedure for Photodynamic Therapy
  • 3.2. Administering Photosensitizers To Body
  • 3.3. Oxygen - The Vital Substrate in Photodynamic Therapy
  • 3.4. Light Source - For Safe & Effective Activation of the Photosensitizer

4. Improving The Photodynamic Therapy Efficacy Through Photosensitizer Delivery

  • 4.1. Role of Organic Nano Particles: Amplified Drug Loading & Increasing The Solubility
  • 4.2. Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy

5. Anti-Tumor Activity of the Photodynamic Therapy

  • 5.1. Direct Tumor Photodynamic Therapy Damage
  • 5.2. Vascular Damage
  • 5.3. Inflammatory & Immune Response

6. Multiple Cancer Treatments Using Photodynamic Therapy

  • 6.1. Non-Melanoma Skin Cancer
  • 6.2. Prostate Cancer
  • 6.3. Breast Cancer
  • 6.4. Brain Tumor
  • 6.5. Lung Cancer
  • 6.6. Head & Neck Cancer
  • 6.7. Oral Lesions & Oesophageal Cancer
  • 6.8. Cervical Cancer
  • 6.9. Colorectal Cancer
  • 6.10. Cancer of the Bile Duct and the Pancreas

7. Combinational Photodynamic Cancer Therapy - Step Towards Complete Eradication Of Tumor Growth

8. Advancements in the Photodynamic Therapy Segment

  • 8.1. Intracellular “Activated” Two-Photon photodynamic Therapy for Breast Cancer
  • 8.2. Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
  • 8.3. Photodynamic Therapy & Combinational Therapy using Microbial Adjuvants & Cytokines

9. Global Cancer Photosensitisers Clinical Pipeline Overview

  • 9.1. By Phase
  • 9.2. By Country
  • 9.3. By Company

10. Global Cancer Photosensitisers Clinical Pipeline By Company, Indication & Phase

  • 10.1. Research
  • 10.2. Preclinical
  • 10.3. Phase-II
  • 10.4. Phase-III

11. Marketed Cancer Photosensitisers By Company & Indication

  • 11.1. Ameluz
  • 11.2. UVADEX
  • 11.3. Photobarr/ Photofrin
  • 11.4. Foscan
  • 11.5. Cevira
  • 11.6. Metvix
  • 11.7. TOOKAD Soluble
  • 11.8. Aptocine/ Laserphyrin/ Leserfin/ Litx

12. Commercial Information Revealing the Industry In-sights for Photodynamic Therapy

  • 12.1. Advancing the Photodynamic Therapy by a Novel Compound
  • 12.2. Adaption of New Techniques for Making Photodynamic Therapy Effective & More Ceaper
  • 12.3. Replacing Oxygen Dependent Drugs with More Efficient Compounds
  • 12.4. Researchers Revolutionizing the Era of Surgical Injections into Gels

13. Global Photodynamic Therapy Market: Current Scenario & its Role in the Oncology Segment

  • 13.1. Global Photodynamic Therapy Market Analysis
  • 13.2. North America
  • 13.3. Europe
  • 13.4. Asia Pacific
  • 13.5. Latin America, Middle East & Africa

14. Global Photodynamic Cancer Therapy Market Dynamics

  • 14.1. Favorable Parameters for the Growth
  • 14.2. Challenges to Future Market Growth

15. Global Photodynamic Cancer Therapy Market Future Outlook

16. Competitive Landscape

  • 16.1. Theralase Technologies
  • 16.2. Dusa Pharmaceuticals
  • 16.3. Biofrontera AG
  • 16.4. Soligenix
  • 16.5. Coherent
  • 16.6. Lumenis
  • 16.7. Nanoprobes
  • 16.8. PhotoMedex
  • 16.9. Biolitec
  • 16.10. Ambicare Health
  • 16.11. Quest Pharma Tech
  • 16.12. Photolitec
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.